GDF-15

GDF-15 분자 정보

영어 이름Growth/differentiation factor 15시판 약물 수0
임상 약물 수10표적 별명Placental TGF-beta,GDF-15,MIC1,PTGFB,MIC-1,PLAB,NSAID-activated gene 1 protein,Growth Differentiation Factor 15,Non-Steroidal Anti-Inflammatory Drug-Activated Gene-1,Placental Bone Morphogenetic Protein,NRG-1,PDF,Growth/Differentiation Factor 15,Macrophage Inhibitory Cytokine-1,PTGF-Beta,NSAID-regulated gene 1 protein,GDF15,Prostate Differentiation Factor,Macrophage Inhibitory Cytokine 1,NAG-1,NSAID (Nonsteroidal Anti-Inflammatory Drug)-Activated Protein 1
최고 연구 개발 단계Phase 3 Clinical
영어 이름Growth/differentiation factor 15
표적 별명Placental TGF-beta,GDF-15,MIC1,PTGFB,MIC-1,PLAB,NSAID-activated gene 1 protein,Growth Differentiation Factor 15,Non-Steroidal Anti-Inflammatory Drug-Activated Gene-1,Placental Bone Morphogenetic Protein,NRG-1,PDF,Growth/Differentiation Factor 15,Macrophage Inhibitory Cytokine-1,PTGF-Beta,NSAID-regulated gene 1 protein,GDF15,Prostate Differentiation Factor,Macrophage Inhibitory Cytokine 1,NAG-1,NSAID (Nonsteroidal Anti-Inflammatory Drug)-Activated Protein 1
시판 약물 수0
임상 약물 수10
최고 연구 개발 단계Phase 3 Clinical

GDF-15 제품 목록

  • 속성

    Protein (6)Kits (1)

  • 제품 라이브러리

    온라인 (7)

  • Human (5)Cynomolgus (1)Mouse (1)

  • 태그

    His Tag (3)Fc Tag (1)Avi Tag & Fc Tag (1)His Tag & Avi Tag (1)- (1)

  • 마커

    Unconjugated (4)Biotin-labeled (2)- (1)

GDF-15분자 배경

Growth Differentiation Factor 15 (GDF-15), also called Macrophage Inhibitory Cytokine 1 (MIC-1). Expression of MIC-1 mRNA in monocytoid cells is up-regulated by a variety of stimuli associated with activation, including interleukin 1β, tumor necrosis factor α (TNF-α), interleukin 2, and macrophage colony-stimulating factor but not interferon γ, or lipopolysaccharide (LPS). It is highly expressed in cardiomyocytes, adipocytes, macrophages, endothelial cells, and vascular smooth muscle cells in normal and pathological condition. GDF-15 increases during tissue injury and inflammatory states and is associated with cardiometabolic risk. Increased GDF-15 levels are associated with cardiovascular diseases such as hypertrophy, heart failure, atherosclerosis, endothelial dysfunction, obesity, insulin resistance, diabetes, and chronic kidney diseases in diabetes. Increased GDF-15 level is linked with the progression and prognosis of the disease condition.

GDF-15분자 별명

GDF15,GDF-15,MIC-1,MIC1,NAG-1,PDF,PLAB,PTGFB,NRG-1

항체 프로젝트 거래 플랫폼

프로젝트 이름프로젝트 단계분자 유형분자 출처질병 영역적응증
GDF15 mAb - 01PCCMonoclonalHumanized MouseMetabolismSolid tumor,Cancer cachexia

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
VisugromabCTL-002Phase 3 ClinicalCatalYm GmbHCachexia; Carcinoma, Non-Small-Cell Lung; Solid tumours; Urinary Bladder Neoplasms
상세
PonsegromabPF-06946860Phase 3 ClinicalPfizer IncAnorexia; Breast Neoplasms; Cachexia; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Fatigue; Feeding and Eating Disorders; Heart Failure; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms
상세
NGM-120NGM-120Phase 2 ClinicalNGM Biopharmaceuticals IncAnorexia; Cachexia; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Esophageal Neoplasms; Hyperemesis Gravidarum; Melanoma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Urinary Bladder Neoplasms
상세
GDF15 agonist (Lilly)Phase 1 ClinicalEli Lilly And CompanyDiabetes Mellitus
상세
NN-9215Human-GDF15; MIC-1; NN-9215; LA-GDF15Phase 1 ClinicalNovo Nordisk A/SObesity
상세
GFS-202-AGFS-202-A; GFS202APhase 1 ClinicalGenfleet Therapeutics (Shanghai) Co LtdCachexia
상세
GB-18GB-18; GB18Phase 1 ClinicalShandong Kexing Bio-Products Co LtdCachexia
상세
CIN-109CIN-109; JNJ-9090Phase 1 ClinicalJanssen Sciences Ireland Unlimited CompanyObesity
상세
MBL-949MBL-949Phase 1 ClinicalNovartis Pharma AgDiabetes Mellitus; Obesity
상세
AV-380AV-380Phase 1 ClinicalAveo Pharmaceuticals IncCachexia
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호